This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignee: Los Alamos National Security, LLC. Active years: 2009-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2017
Title: The Innovative Contributions of Andrew M. Bradbury
Introduction
Andrew M. Bradbury is a notable inventor based in Santa Fe, NM (US), recognized for his significant contributions to the field of biotechnology. With a total of 9 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies and protein engineering.
Latest Patents
Among his latest patents is a method for generating polynucleotides encoding enhanced folding variants. This invention provides directed evolution methods aimed at improving the folding, solubility, and stability characteristics of polypeptides. It includes a method for generating folding and stability-enhanced variants of proteins, such as fluorescent proteins, chromophoric proteins, and enzymes. Another significant patent involves the development of humanized recombinant and monoclonal antibodies specific for the ectodomain of the influenza virus M2 ion channel protein. These antibodies exhibit anti-viral activity and hold potential as therapeutic agents for treating influenza infections.
Career Highlights
Andrew M. Bradbury is currently employed at Los Alamos National Security, LLC, where he continues to push the boundaries of scientific research and innovation. His work has been instrumental in advancing the understanding of protein stability and therapeutic applications.
Collaborations
Throughout his career, Bradbury has collaborated with esteemed colleagues, including Geoffrey S. Waldo and Csaba Kiss, contributing to a rich environment of innovation and discovery.
Conclusion
Andrew M. Bradbury's contributions to biotechnology and his innovative patents underscore his role as a leading inventor in his field. His work not only enhances our understanding of protein dynamics but also paves the way for new therapeutic strategies against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
